Hypofractionation in adjuvant breast radiotherapy

Breast

Volumn 19, Issue 3, 2010, Pages 168-171

  Khan, Atif ^a   Haffty, Bruce G ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Breast cancer; Hypofractionation; Radiation therapy; Radiobiology; Toxicity

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE;

ARTICLE; BRACHIAL PLEXUS NEUROPATHY; BRACHYTHERAPY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; ELECTRON THERAPY; HEART DISEASE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MASTECTOMY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RIB FRACTURE; SKIN TOXICITY; TELANGIECTASIA; THERAPY EFFECT; TREATMENT OUTCOME; ADJUVANT THERAPY; BREAST NEOPLASMS; FEMALE; PATHOLOGY;

BREAST NEOPLASMS; DOSE FRACTIONATION; FEMALE; HUMANS; RADIOTHERAPY, ADJUVANT;

EID: 77953346658     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2010.03.004     Document Type: Article

References (19)

1. Fowler J. The linear-quadratic formula and progress in fractionated radiotherapy. British Journal of Radiology 1989, 62:679-694.
2. Bentzen S., Baumann M. The linear-quadratic model in clinical practice. Basic clinical radiobiology 2002, 134-146. Arnold, London. G. Steel (Ed.).
3. Rosenstein B., Lymberis S., Formenti S. Biologic comparison of partial breast irradiation protocols. International Journal of Radiation Oncology Biology and Physics 2004, 60:1393-1404.
4. Matthews J., Meeker B., Chapman J. Response of human tumor cell lines in vitro to fractionated irradiation. International Journal of Radiation Oncology Biology and Physics 1989, 16:133-138.
5. Steel G., Deacon J., Duschesne G. The dose-rate effect in human tumour cells. Radiotherapy and Oncology 1987, 9:299-310.
6. Cohen L. Radiotherapy in breast cancer. The dose-time relationship: theoretical considerations. British Journal of Radiology 1952, 25:636-642.
7. Douglas B., Castro J. Novel fractionation schemes and high linear energy transfer. Progress in Experimental Tumor Research 1984, 28:152-165.
8. Owen J.R., Ashton A., Bliss J.M., Homewood J., Harper C., Hanson J., et al. Effect of radiotherapy fraction size on tumor control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncology 2006, 7:467-471.
9. Yarnold J., Ashton A., Bliss J., Homewood J., Harper C., Hanson J., et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiotherapy and Oncology 2005, 75:9-17.
10. The_START_trialists_group The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncology 2008, 9:331-341.
11. The_START_trialists_group The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomized trial. Lancet 2008, 371:1098-1107.
12. Whelan T., MacKenzie R., Julian J., Levine M., Shelley W., Grimard L., et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. Journal of the National Cancer Institute 2002, 94:1143-1150.
13. Bartelink H., Horiot J.C., Poortmans P.M., Struikmans H., Van den Bogaert W., Fourquet A., et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. New England Journal of Medicine 2001, 345:1378-1387.
14. Baillet F., Housset M., Maylin C., Boisserie G., Bettahar R., Delanian S., Habib F. The use of a specific hypofractionated radiation therapy regimen versus classical fractionation in the treatment of breast cancer: a randomized study of 230 patients. International Journal of Radiation Oncology Biology and Physics 1990, 19:1131-1133.
15. Ortholan C., Hannoun-Levi J., Ferrero J., Largillier R., Courdi A. Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patients. International Journal of Radiation Oncology Biology and Physics 2005, 61:154-162.
16. Kirova Y.M., Campana F., Savignoni A., Laki F., Muresan M., Dendale R., et al. Breast-conserving treatment in the elderly: long term results of adjuvant hypofractionated and normofractionated radiotherapy. International Journal of Radiation Oncology Biology and Physics 2009, 75:76-81.
17. Formenti S.C., Gidea-Addeo D., Goldberg J.D., Roses D.F., Guth A., Rosenstein B.S., DeWyngaert K.J. Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. Journal of Clinical Oncology 2007, 25:2236-2242.
18. Ivaldi G.B., Leonardi M.C., Orecchia R., Zerini D., Morra A., Galimberti V., et al. Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women. International Journal of Radiation Oncology Biology and Physics 2008, 72:485-493.
19. Chadha M., Woode R., Silanpaa J., Feldman S., Boolbol S., Furnhang E., Harrison L.B. Three-week accelerated radiation therapy (ART) schedule with a concomitant in-field boost as treatment for early stage breast cancer. International Journal of Radiation Oncology Biology and Physics 2007, 69:S137. abstract 1004.